View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Our new building on the hospital campus, Forest B, is open. Families and visitors can park in the new Forest B garage next to Emergency.

Search Results

Search Results for “”.

AALL1821: Phase 2 Study of Blinatumomab (NSC# 765986, IND# 125462) in Combination with Nivolumab (NSC # 748726, IND# 125462), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged ≥ 1 to < 31 Years Old with First Relapse-STUDY00003220

This is a phase 2 study for 1st relapse B-ALL. The large goal is to try to induce remission in the highest risk group of patients with...
Accuracy Performance Verification of the INVOS PM7100 System in the Pediatric Cardiac Catheterization Laboratory (INCATH)-STUDY00004469

To verify INVOS cerebral oximetry system performance in pediatric and infant patients by comparing regional oxygen saturation (rSO2) values
AALL2131 An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors with Blinatumomab in Patients with Newly-Diagnosed Philadelphia Chromosome-Positive or ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leu-STUDY00005534

AALL2131 is a multi-center, international clinical trial designed to improve outcomes and reduce treatment-related toxicity in pediatric patients...
Achieving Health in Emerging Adults Diabetes Program (AHEAD)-STUDY00005176

A clinical program designed to support emerging adults with type 1 diabetes.
ACcomplisH: A Phase 2, multicenter, double-blind, randomized, placebo-controlled, dose escalation trial evaluating safety, efficacy, and pharmacokinetics of subcutaneous doses of TransCon CNP administered once weekly for 12 months in prepube-STUDY00002415

The trial is a multicenter, double-blind, randomized, placebo-controlled, dose escalation trial of weekly TransCon CNP administered subcutaneously...
A Phase 3, Prospective, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Paricalcitol Oral Solution for the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects Ages 0 to 9 Years with Stage 5-STUDY00002090

THis Phase 3 multi center study will evaluate the safety, efficacy and pharmacokinetics of paricalcitol oral solution for the treatment of...
A multicenter access and distribution protocol for unlicensed cryopreserved cord blood unios (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications-PIROSTUDY14135

Iron Mountain Box # 676416053
COVID-19 Research Areas

COVID-19 Research Areas
Clinical Trials Listing by Category

Clinical Trials Clinical Trials Clinical Trials Listing by Category The listing category is Anxiety of which there are 5 trials in SDS that should be...
Wendy Lynn Taylor, ARNP, DNP

Wendy Lynn Taylor, ARNP, DNP